SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA -- Ignore unavailable to you. Want to Upgrade?


To: ED_L who wrote (777)11/14/1998 12:21:00 PM
From: amiles  Respond to of 897
 
you'll want to read back through the posts to this bb... the product is Oratest, and the co has a few other lines of biz as well... big delay with the FDA now apparently over and we're on the fast-track... the remaining question is whether the Oratest will actually sell... it would seem like a no-brainer, but it has been approved for sale in various countries and so far hasn't sold much... this may be a mgmt problem, not a product problem... also, the co has had to structure some stock-for-cash deals to stretch itself through this past year, and there's some dilution from that... but this co is now poised to do whatever it is fated to do, where only a week ago we were in seemingly endless limbo... if you wanna bet on it, now's probably the time...



To: ED_L who wrote (777)11/15/1998 3:16:00 AM
From: Steven F. Woolf  Respond to of 897
 
ED_L wrote:

"Also talked about a possibility of a buyout if one of the majors decided they needed the product to fill a niche."

One thing you can be sure of: if OraTest is approved, it is hardly a "niche" product. We're talking worldwide standard if all goes as planned.

Steve